Letko, Brosseau & Associates’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223K | Hold |
16,500
| – | – | ﹤0.01% | 86 |
|
|
2025
Q1 | $262K | Hold |
16,500
| – | – | 0.01% | 78 |
|
|
2024
Q4 | $203K | Buy |
16,500
+5,100
| +45% | +$62.8K | ﹤0.01% | 93 |
|
|
2024
Q3 | $138K | Hold |
11,400
| – | – | ﹤0.01% | 96 |
|
|
2024
Q2 | $133K | Hold |
11,400
| – | – | ﹤0.01% | 99 |
|
|
2024
Q1 | $147K | Hold |
11,400
| – | – | ﹤0.01% | 98 |
|
|
2023
Q4 | $98K | Hold |
11,400
| – | – | ﹤0.01% | 93 |
|
|
2023
Q3 | $108K | Hold |
11,400
| – | – | ﹤0.01% | 93 |
|
|
2023
Q2 | $194K | Buy |
+11,400
| New | +$194K | ﹤0.01% | 88 |
|